NCT06592014
Lithium for Parkinson's: an Extension Trial
Enrolling by Invitation
PHASE1Ages 45–80InterventionalTreatmentState University of New York at BuffaloInvestigator-initiated
~35 participants
Updated 2026-08-25 on ClinicalTrials.gov
What's tested:Lithium aspartate
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Free Water
Measured over 24 Weeks.
+1 more outcome measured
Conditions
NCT06592014
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
UBMD Neurology
Williamsville, New Yorkno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Thomas Guttuso, MD · PRINCIPAL_INVESTIGATOR · University at Buffalo
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Free Water24 Weeks.
Change in MRI-assessed free water in posterior substantia nigra, dorsomedial nucleus of the thalamus and nucleus basalts of Meynert.
- Serum neurofilament light chain24 weeks
Change in serum neurofilament light chain